Regarding antifungal therapy, seven out of eight cases of IPA received combined antifungal treatment with LAMB and voriconazole, although current guidelines based on randomized clinical trials promote monotherapy with voriconazole or isavuconazole. The gene discussed is GRAMD1B; the disease is Ito hypomelanosis.